[Treatment of Takayasu's disease with low-dose methotrexate. Apropos of a case]

Rev Rhum Ed Fr. 1994 Jun;61(6):466-9.
[Article in French]

Abstract

Persistent evidence of inflammation at the occlusive phase of Takayasu's arteritis is of adverse prognostic significance. Low-dose weekly methotrexate therapy given in combination with a corticosteroid may be effective in such patients. We report a personal case which supports the data obtained by Fauci and coworkers, as well as the conclusions of the other two similar case-reports in the literature.

Publication types

  • Case Reports
  • English Abstract
  • Review

MeSH terms

  • Drug Therapy, Combination
  • Female
  • Humans
  • Methotrexate / administration & dosage
  • Methotrexate / therapeutic use*
  • Middle Aged
  • Prednisone / therapeutic use
  • Takayasu Arteritis / drug therapy
  • Time Factors

Substances

  • Prednisone
  • Methotrexate